Klinik und Poliklinik für Allgemein-, Viszeral- und Transplantationschirurgie
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
50
2019 - 2021
Grifols Fibrin Sealant (Clinical trial) - Auftragsforschung- Univ.-Prof. Dr. OliverMuensterer,
- Dr. Tatjana TamaraKönig
2018
BionTech RB_02 Forschungsprojekt BionTech Gewebeentnahme bei OP und Blutentnahme bei Aufnahme- Univ.-Prof. Dr. HaukeLang,
- PD Dr. StefanHeinrich
2018 - 2019
Rezidive von intrahepatischen cholangiozellulären Karzinomen – Nationale, multizentrische Erfassung der chirurgischen Therapie- Univ.-Prof. Dr. HaukeLang,
- Dr. FabianBartsch
2018 - 2021
AVATAR: Development of augmented and virtual multi-user applications for medical-technical exchange in immersive rooms.Subproject: virtual and augmented systems for surgical education and training- Prof. Dr. WernerKneist,
- Dr. TobiasHuber
2018 - 2025
Molecular and clinical analysis of papillary thyroid carcinoma- Prof. Dr. Thomas J.Musholt,
- Dr. JuliaStaubitz
2017
12th Biennial E-AHPBA Congress 2017: 23 - 26 May (European-African Hepato Pancreato Biliary Association)- Prof. Dr. HaukeLang,
- Dr. StefanHeinrich
2016 - 2018
Development of a virtual-reality simulation system for liver surgery- Prof. Dr. HaukeLang,
- Dr. MarkusPaschold
2015 - 2019
Esopec (An investigator-initiated multicenter prospective randomized controlled two-arm trial, comparing the efficacy of neoadjuvant chemoradiation (CROSS protocol: 41.4Gy plus carboplatin/paclitaxel) followed by surgery versus perioperative chemotherapy and surgery (FLOT protocol: 5-FU/leucovorin/oxaliplatin/docetaxel) for the curative treatment of localized esophageal adenocarcinoma)- PD Dr. PeterGrimminger,
- PD Dr. StefanHeinrich
2015 - 2020
Gastripec I (Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study)- Univ.-Prof. Dr. HaukeLang,
- PD Dr. PeterGaßmann,
- Dr. Peter P.Grimminger
2015 - 2018
A prospective randomized controlled trial to evaluate computer-assisted 3 D-navigation in liver resections (NaLiS)- Univ.-Prof. Dr. HaukeLang,
- Dr. TobiasHuber
2015 - 2017
Gene Regulation of the tumorsuppressor insulin-like growth factor-2 receptor (IGF2R) in human hepatocellular carcinoma (HCC) and its prognostic relevance- Dr. AnjaLautem,
- PD Dr. TimZimmermann
2015 - 2017
Significance of DNA methylation and histone acetylation/methylation in the region of the gene locus 6q26-27 for the progression of hepatocellular carcinoma (HCC)- Dr. AnjaLautem,
- PD Dr. TimZimmermann
2015 - 2017
Analysis of single nucleotid polymorphisms (SNPs) in the insulin-like growth factor-2 receptor (IGF2R) promoter region of patients with hepatocellular carcinoma (HCC)- Dr. AnjaLautem,
- PD Dr. TimZimmermann
2015 - 2017
Influence of transarterial chemoembolization (TACE) of patients with HCC on the regulation of insulin-like growth factor-2 receptor (IGF2R) and its prognostic relevance after liver transplantation- Dr. AnjaLautem,
- PD Dr. TimZimmermann
2015 - 2020
Eurocrine® (European Surgical Registry for Rare Endocrine Tumours)- Prof. Dr. Thomas J.Musholt,
- F.Angeletti,
- Dr. AntjeGohrbandt,
- C.Schwarz,
- Dr. FelixWatzka,
- Dr. EvangelosTagkalos,
- Prof. Dr. HaukeLang
2015 - 2020
“Prospective Evaluation Study for Identification of False Negative Causes in Electromyographical Monitored Thyroid Surgery (IFAN)” (Version 1.2) International IONM Study Group- Prof. Dr. Thomas J.Musholt,
- KhaledAlghdban,
- Dr. AntjeGohrbandt,
- Dr. FelixWatzka,
- F.Angeletti,
- C.Schwarz,
- A.Naber,
- AB.Röpke,
- Prof. Dr. HaukeLang
2015 - 2020
EORTC QOL Module for Thyroid Cancer (QLQ-THY) EORTC QLQ-THY47- Prof. Dr. Thomas J.Musholt
2015 - 2020
ENS@T - the European Network for the Study of Adrenal Tumors - is a European consortium, founded to investigate rare adrenal tumors.- Prof. Dr. Thomas J.Musholt
2015 - 2020
TONIC Total versus near-total thyroidectomy in Graves’ disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?- Prof. Dr. Thomas J.Musholt,
- K.Maschuw,
- K.Schlosser,
- D.Lubbe,
- C.Nies,
- DK.Bartsch,
- C.Schwarz
2015 - 2020
Lebensqualität und Nebenschilddrüsenfunktion nach operativer Behandlung von Schilddrüsenkrebs- Prof. Dr. Thomas J.Musholt,
- C.Schwarz,
- S.Singer
2015 - 2020
Differential protein composition and gene expression in endocrine and neuroendocrine tumors- Prof. Dr. Thomas J.Musholt,
- K.Rajalingam,
- MM.Weber
2014 - 2016
Factor XIII-study - evaluation of factor XIII as possible cause of surgerical complications in liver and pancreatic surgery- PD Dr. StefanHeinrich
2013 - 2014
Bedeutung der DNA-Methylierung und der Histonacetylierung/-methylierung im Bereich des Genlocus 6q26-27 für die Progression des hepatozellulären Karzinoms (HCC)- Dr. AnjaLautem,
- PD Dr. TimZimmermann
2013 - 2014
Etablierung von Referenzwerten für die High-Resolution Impedanz Manometrie für ein erweitertes klinisches „Schluckprotokoll“- Dr. StefanNiebisch
2013 - 2014
Ineffective Esophageal Motility (IEM) Re-Defined through HR-Impedance Manometry- Dr. StefanNiebisch
2013 - 2014
Postoperative Esophageal Pressure Topography (EPT) Classification of Idiopathic Achalasia- Dr. StefanNiebisch
2013 - 2014
Does Re-Anchoring of the EGJ in Patients with Paraesophageal Hiatal Hernie lead to Improvement of Esophageal Motility?- Dr. StefanNiebisch
2013 - 2015
Dysphonie und Schluckstörungen nach Schilddrüsenresektionen- Univ.-Prof. Dr. Thomas J.Musholt,
- A.Aschoff,
- Dr. AntjeGohrbandt,
- ChristinaSchwarz,
- FlaviaAngeletti,
- Dr. FelixWatzka,
- Univ.-Prof. Dr. AnneroseKeilmann
2013 - 2015
Molekulargenetische Analyse von Feinnadelpunktaten der Schilddrüse zur Diagnose papillärer Schilddrüsenkarzinome- Univ.-Prof. Dr. Thomas J.Musholt,
- Dr. ArnoSchad,
- Dr. FelixWatzka,
- ChristinaSchwarz,
- Dr. AntjeGohrbandt,
- FlaviaAngeletti,
- Dr. WaltraudEichhorn,
- PD Dr. ChristianFottner,
- Univ.-Prof. Dr. Matthias M.Weber,
- Univ.-Prof. Dr. JoachimPohlenz
2013 - 2015
Prognostische Bedeutung von BRAF, RET/PTC und NTRK1-Mutationen für den Verlauf papillärer Schilddrüsenkarzinome- Univ.-Prof. Dr. Thomas J.Musholt,
- Dr. ArnoSchad,
- Dr. FelixWatzka,
- ChristinaSchwarz,
- Dr. AntjeGohrbandt,
- FlaviaAngeletti,
- Dr. WaltraudEichhorn,
- PD Dr. ChristianFottner,
- Univ.-Prof. Dr. Matthias MWeber,
- Univ.-Prof. Dr. JoachimPohlenz
2013 - 2015
Immunhistochemische Untersuchung papillärer Schilddrüsenkarzinome mittels eines BRAF-Antikörpers- Univ.-Prof. Dr. Thomas J.Musholt,
- S.Bitok,
- Dr. A.Schad,
- Dr. W.Eichhorn,
- PD Dr. C.Fottner,
- Prof. Dr. M.M.Weber,
- Univ.-Prof. Dr. J.Pohlenz
2013 - 2015
Genetic and immunohistochemic characterization of poorly differentiated thyroid carcinoma (PDTC)- Univ.-Prof. Dr. Thomas J.Musholt,
- Dr. A.Schad,
- T.Gerber
2013 - 2015
Entwicklung eines netzwerkfähigen Mainzer Dokumentations- und Analysesystems (MaDoC) für Patienten mit neuroendokrinen Tumoren des gastro-enteropankreatischen Systems (GEP-NET)- Univ.-Prof. Dr. Thomas JMusholt,
- Dr. FWatzka,
- CSchwarz,
- Dr. AGohrbandt,
- FAngeletti,
- Univ.-Prof. Dr. HaukeLang,
- PD Dr. CFottner,
- Univ.-Prof. Dr. MMWeber
2013 - 2015
Kontinuierliches Neuromonitoring des N. recurrens bei Schilddrüsen- und Nebenschilddrüsen-Operationen- Univ.-Prof. Dr. TJMusholt,
- FAngeletti,
- Dr. AGohrbandt,
- CSchwarz,
- Dr. FWatzka,
- Dr. ETagkalos,
- ANaber,
- ABRöpke,
- Univ.-Prof. Dr. HaukeLang
2013 - 2015
Dokumentation und Analyse von Patienten mit neuroendokrinen Tumoren des gastro-enteropankreatischen Systems (GEP-NET) im Rahmen eines nationalen Tumorregisters (NET-Register)- Univ.-Prof. Dr. TJMusholt,
- Dr. FWatzka,
- CSchwarz,
- Dr. AGohrband,
- FAngeletti,
- Univ.-Prof. Dr. HaukeLang,
- PD Dr. CFottner,
- Univ.-Prof. Dr. MMWeber